INTRODUCTION
Sclerosing encapsulating peritonitis (SEP) is a rare cause of intestinal obstruction that is characterized by the partial or complete encasement of the small bowel by a thick, white, and fibrous membrane. SEP was first described as "peritonitis chronica fibrosa encapsulate" in 1907. 1 (Fig. 1 ). Abdominal CT showed large amounts of ascites and ileal loops encapsulated by soft tissue with dilatation of the proximal small bowel on the right side of the abdomen (Fig. 2) . Barium follow-through showed conglomerated distal ileal loops with a cauliflower-like appearance. Palpation did not separate these conglomerated bowel loops, but allowed passage of contrast medium (Fig. 3 ). On the basis of these findings, the patient was diagnosed with partial small bowel obstruction due to SEP. As his symptoms were recurrent and did not improve with conservative management, exploratory laparotomy was performed, which showed a thick, fibrous, and white capsule encapsulating the ileal loop (Fig. 4A) . The capsule was dissected and excised, releasing a 1.5-m section of the small bowel (Fig. 4B) . Histopathological examination of the capsule revealed a dense fibrous wall without epithelial lining (Fig. 5) . The postoperative period was uneventful, and symptoms improved after the procedure. Propranolol was stopped after surgery. The patient has been receiving conservative management for LC and hemodialysis for 58 months after the surgery, without recurrence of bowel obstruction. 
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DISCUSSION
SEP is a rare clinical entity that can cause acute, subacute, or chronic small intestinal obstruction. This condition is characterized by a thick, fibrotic, and cocoon-like membrane, which partially or totally encases the small bowel. 2, 6 Long-term peritoneal stimulation, which can occur with CAPD, is thought to be a primary cause for secondary SEP. 4, 5 Other reported associations include abdominal tuberculosis, 7 long-term use of β-adrenergic blockers, 6,8-13 ventriculoperitoneal or peritoneovenous shunts in patients with LC, 14 orthotropic liver transplantation, 15 and sarcoidosis. 16 The association between SEP and the β-adrenergic blocker, practolol, was first reported in 1974. 8 Other β-adrenergic blockers associated with SEP include timolol, 9 metoprolol, 12 and atenolol. 13 There have been two reports on SEP associated with propranolol administered for the treatment of chronic angina pectoris, 10, 11 and one on SEP in a patient with LC who was taking a propranolol for over 4 years. 6 Two mechanisms by which β-adrenergic blockers can cause SEP have been suggested, including enhanced collagen production, or an allergic reaction to the drug. 11, 17 Our patient had been taking propranolol for 15 years and had no history of SBP or CAPD. Moreover, there was no evidence of other reported conditions commonly linked to SEP. Thus, we suspect that propranolol may have played a role in the development of secondary SEP in our patient. Preoperative diagnosis of SEP is challenging, and a consid- A B www.irjournal.org erable number of patients are diagnosed with SEP at laparotomy. Accordingly, clinicians should evaluate the possibility of SEP in cases with compatible history and symptoms of this condition to ensure the appropriate management of patients. Radiologically, barium follow-through studies usually show the ileal loops clumped together within a sac having a cauliflower-like appearance. 3 Abdominal CT can reveal small bowel loops congregated to the center of the abdomen and encased by a soft tissue density mantle, making it look like a cocoon. 18 Consistent with these observations, typical features of conglomerated and encapsulated bowel loops on both barium study and CT, were seen in the present case. SEP can be managed medically or surgically. Surgical intervention usually includes the careful and complete removal of the covering membrane and adhesiolysis of the dense interbowel adhesions. 6 According to one report, SEP can be successfully treated by total enterolysis and the oral administration of prednisolone 5 mg/day. 19 Others reported a lower mortality rate after treatment with tamoxifen in patients with PD-related SEP. 20 Conservative therapy, including long-term intravenous hyperalimentation and Levin tube drainage, may be an alternative to surgery in patients with sub-acute intestinal obstruction. 6 Our patient was initially managed conservatively, with nil per os and parenteral nutrition, because of the risk associated with surgery related to poor hepatic function. Surgical intervention was later required, however, because his symptoms did not improve with conservative management. Prednisolone was not given to our patient due to a history of chronic hepatitis B.
In conclusion, SEP is a rare cause of intestinal obstruction with an uncertain pathophysiology. SEP should be considered in the differential diagnosis of patients with small bowel obstruction who receive long-term treatment with β-adrenergic blockers.
